Literature DB >> 15201258

Low grade inflammation is notably suppressed by conventional anti-inflammatory treatment: a randomised crossover trial.

C G Perry, S J Cleland, J M Connell, J R Petrie, N Sattar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15201258      PMCID： PMC1768325          DOI： 10.1136/hrt.2003.022129

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  4 in total

1.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.

Authors:  Thomas A Pearson; George A Mensah; R Wayne Alexander; Jeffrey L Anderson; Richard O Cannon; Michael Criqui; Yazid Y Fadl; Stephen P Fortmann; Yuling Hong; Gary L Myers; Nader Rifai; Sidney C Smith; Kathryn Taubert; Russell P Tracy; Frank Vinicor
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

2.  Strong decrease of high sensitivity C-reactive protein with high-dose atorvastatin in patients with type 2 diabetes mellitus.

Authors:  M A van de Ree; M V Huisman; H M G Princen; A E Meinders; C Kluft
Journal:  Atherosclerosis       Date:  2003-01       Impact factor: 5.162

3.  Immunosuppressive Therapy for the Prevention of Restenosis after Coronary Artery Stent Implantation (IMPRESS Study).

Authors:  Francesco Versaci; Achille Gaspardone; Fabrizio Tomai; Flavio Ribichini; Paolo Russo; Igino Proietti; Anna Silvia Ghini; Valeria Ferrero; Luigi Chiariello; Pier Agostino Gioffrè; Francesco Romeo; Filippo Crea
Journal:  J Am Coll Cardiol       Date:  2002-12-04       Impact factor: 24.094

4.  Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels.

Authors:  I Jialal; D Stein; D Balis; S M Grundy; B Adams-Huet; S Devaraj
Journal:  Circulation       Date:  2001-04-17       Impact factor: 29.690
  4 in total
  2 in total

1.  Serum markers of apoptosis decrease with age and cancer stage.

Authors:  Nilay Kavathia; Alka Jain; Jeremy Walston; Brock A Beamer; Neal S Fedarko
Journal:  Aging (Albany NY)       Date:  2009-07-14       Impact factor: 5.682

2.  Endothelial dysfunction and low-grade inflammation in the transition to renal replacement therapy.

Authors:  April C E van Gennip; Natascha J H Broers; Karlien J Ter Meulen; Bernard Canaud; Maarten H L Christiaans; Tom Cornelis; Mariëlle A C J Gelens; Marc M H Hermans; Constantijn J A M Konings; Jeroen B van der Net; Frank M van der Sande; Casper G Schalkwijk; Frank Stifft; Joris J J M Wirtz; Jeroen P Kooman; Remy J H Martens
Journal:  PLoS One       Date:  2019-09-13       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.